Shanghai Pharmaceuticals Holding Co., Ltd (ADR)
General ticker "SHPMY" information:
- Sector: Health Care
- Industry: Medical - Distribution
- Capitalization: $5.7B (TTM average)
Shanghai Pharmaceuticals Holding Co., Ltd (ADR) follows the US Stock Market performance with the rate: 30.6%.
Estimated limits based on current volatility of 0.0%: low 8.23$, high 8.23$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-07-17, amount 0.20$ (Y2.43%)
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.49$, 11.64$]
- 2025-12-31 to 2026-12-31 estimated range: [8.59$, 13.19$]
Financial Metrics affecting the SHPMY estimates:
- Positive: with PPE of 9.7 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 2.96
- Positive: 6.82 < Operating cash flow per share per price, % of 13.09
- Positive: Inventory ratio change, % of 0.06 <= 0.84
- Negative: Industry operating cash flow per share per price (median), % of 2.60 <= 5.52
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 2.59
- Positive: -8.75 < Industry operating profit margin (median), % of 0.74
- Positive: Investing cash flow per share per price, % of 0.93 > -0.66
Short-term SHPMY quotes
Long-term SHPMY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CNY231,981.30MM | CNY260,295.09MM | CNY275,250.93MM |
| Operating Expenses | CNY222,966.65MM | CNY252,627.85MM | CNY267,110.22MM |
| Operating Income | CNY9,014.65MM | CNY7,667.23MM | CNY8,140.71MM |
| Non-Operating Income | CNY-206.30MM | CNY-612.94MM | CNY-120.71MM |
| Interest Expense | CNY1,689.28MM | CNY1,663.55MM | CNY1,625.90MM |
| R&D Expense | CNY2,112.20MM | CNY2,204.03MM | CNY2,394.43MM |
| Income(Loss) | CNY8,808.35MM | CNY7,054.30MM | CNY8,020.01MM |
| Taxes | CNY1,816.34MM | CNY1,887.73MM | CNY2,149.99MM |
| Profit(Loss)* | CNY5,617.15MM | CNY3,768.00MM | CNY4,552.53MM |
| Stockholders Equity | CNY67,063.01MM | CNY68,524.14MM | CNY71,675.62MM |
| Inventory | CNY34,460.22MM | CNY36,623.39MM | CNY38,943.67MM |
| Assets | CNY198,134.90MM | CNY211,972.53MM | CNY221,209.43MM |
| Operating Cash Flow | CNY4,743.36MM | CNY5,231.52MM | CNY5,827.26MM |
| Capital expenditure | CNY2,684.86MM | CNY2,970.61MM | CNY2,400.88MM |
| Investing Cash Flow | CNY-12,473.12MM | CNY-2,491.87MM | CNY415.98MM |
| Financing Cash Flow | CNY12,138.59MM | CNY231.85MM | CNY-1,863.93MM |
| Earnings Per Share** | CNY8.06 | CNY5.10 | CNY6.15 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.